Rankings
▼
Calendar
LNTH Q3 2016 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena
LNTH
Lantheus Holdings, Inc.
$5B
Q3 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$73M
Gross Profit
$34M
46.1% margin
Operating Income
$13M
17.2% margin
Net Income
$4M
5.8% margin
EPS (Diluted)
$0.13
QoQ Revenue Growth
-6.3%
Cash Flow
Operating Cash Flow
$15M
Free Cash Flow
$13M
Stock-Based Comp.
$877,000
Balance Sheet
Total Assets
$255M
Total Liabilities
$376M
Stockholders' Equity
-$121M
Cash & Equivalents
$53M
Revenue Segments
US Segment
$132M
86%
International Segment
$21M
14%
← FY 2016
All Quarters
Q4 2016 →